Wedbush Securities’s Dr. Reddy's Laboratories RDY Stock Holding History

Wedbush Securities’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-13,840	Closed	-$204K	–	1229
2021 Q2	$204K	Buy	+13,840	New	+$194K	0.01%	1055
2020 Q2	–	Sell	-30,780	Closed	-$248K	–	1004
2020 Q1	$248K	Hold	30,780	–	–	0.03%	599
2019 Q4	$250K	Hold	30,780	–	–	0.02%	752
2019 Q3	$233K	Buy	30,780 +55	+0.2%	+$409	0.02%	765
2019 Q2	$230K	Buy	30,725 +175	+0.6%	+$1.38K	0.02%	751
2019 Q1	$247K	Sell	30,550 -55	-0.2%	-$418	0.03%	677
2018 Q4	$231K	Buy	30,605 +320	+1%	+$2.25K	0.03%	626
2018 Q3	$210K	Buy	+30,285	New	+$202K	0.02%	751
2018 Q2	–	Sell	-32,785	Closed	-$214K	–	904
2018 Q1	$214K	Hold	32,785	–	–	0.03%	657
2017 Q4	$246K	Hold	32,785	–	–	0.03%	628
2017 Q3	$234K	Buy	32,785 +285	+0.9%	+$2.05K	0.03%	647
2017 Q2	$274K	Hold	32,500	–	–	0.04%	578
2017 Q1	$261K	Hold	32,500	–	–	0.04%	586
2016 Q4	$294K	Buy	32,500 +10,000	+44%	+$93.1K	0.04%	513
2016 Q3	$209K	Buy	+22,500	New	+$215K	0.03%	660

Other funds holding RDY

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $304B AUM 35.64% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Wedbush Securities's RDY Position: Q3 2021 in Review

Wedbush Securities sold out of Dr. Reddy's Laboratories (RDY) in Q3 2021, closing a stake of 13,840 shares — an estimated $204K sold.

Wedbush Securities first reported a position in RDY in Q3 2016 and held it in 15 quarters. The position peaked at $294K in Q4 2016. 149 funds tracked by Wall St. Rank hold RDY as of Q3 2021.

Wedbush Securities reported no remaining Dr. Reddy's Laboratories position as of Q3 2021 after selling out during the quarter.
Wedbush Securities sold 13,840 Dr. Reddy's Laboratories shares in Q3 2021, an estimated $204K.
Wedbush Securities first reported a position in Dr. Reddy's Laboratories in Q3 2016 and held it in 15 quarters.
Wedbush Securities's Dr. Reddy's Laboratories position peaked at $294K in Q4 2016.
149 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2021.

Based on Wedbush Securities's 13F filing for Q3 2021, filed 8 Oct 2021.